Press Release

<< Back
 View printer-friendly version
Editas Medicine to Present at Investor Conferences in May
05/08/17

CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in May.  Details are as follows:

Bank of America Merrill Lynch 2017 Health Care Conference

Date:     Wednesday, May 17, 2017
Forum:     Panel Discussion on Gene Therapy and Gene Editing
Time:     4:40 p.m. ET
Location:     Las Vegas

UBS Global Healthcare Conference

Date:     Monday, May 22, 2017
Forum:     Company Presentation and Breakout Session
Time:     8:00 a.m. ET
Location:     New York

A live webcast of the presentation will be available on the Investors & Media section of the Editas website at www.editasmedicine.com.  An archived replay will be available for approximately 30 days following the presentation.

About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.  The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact
Cristi BarnettEditas Medicine, Inc.
(617) 401-0113
cristi.barnett@editasmed.com

Investor Contact
Mark MullikinEditas Medicine, Inc.
(617) 401-9083
mark.mullikin@editasmed.com 

Primary Logo

Editas Medicine